{"denomUnitsSelected":"Participants","description":"The potential efficacy of the infused cells will be assessed and the substrate cell (TN or TCM) that is most effective based on the TTP of patients who have persisting TN cells to that of patients who have persisting TCM cells 3 months after the last infusion will be determined.","reportingStatus":"NOT_POSTED","timeFrame":"3 months after last infusion","title":"Time to Progression (TTP) Based on Response Evaluation Criteria in Solid Tumors (RECIST) Criteria and RECIST 1.1 Mesothelioma Modified","type":"OTHER_PRE_SPECIFIED"}